Camurus AB (CAMRF)
64.00
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Camurus Shareholders Equity (Quarterly) : 483.59M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 483.59M |
| March 31, 2026 | 464.22M |
| December 31, 2025 | 459.43M |
| September 30, 2025 | 437.74M |
| June 30, 2025 | 406.13M |
| March 31, 2025 | 347.13M |
| December 31, 2024 | 297.73M |
| September 30, 2024 | 307.03M |
| June 30, 2024 | 276.51M |
| March 31, 2024 | 247.43M |
| December 31, 2023 | 148.15M |
| September 30, 2023 | 136.99M |
| June 30, 2023 | 127.94M |
| March 31, 2023 | 102.35M |
| December 31, 2022 | 95.46M |
| September 30, 2022 | 87.27M |
| June 30, 2022 | 86.59M |
| March 31, 2022 | 91.57M |
| December 31, 2021 | 93.76M |
| September 30, 2021 | 94.58M |
| June 30, 2021 | 95.84M |
| March 31, 2021 | 94.94M |
| December 31, 2020 | 103.19M |
| September 30, 2020 | 92.03M |
| Date | Value |
|---|---|
| June 30, 2020 | 58.99M |
| March 31, 2020 | 57.58M |
| December 31, 2019 | 67.47M |
| September 30, 2019 | 42.51M |
| June 30, 2019 | 51.79M |
| March 31, 2019 | 60.51M |
| December 31, 2018 | 28.46M |
| September 30, 2018 | 38.18M |
| June 30, 2018 | 42.81M |
| March 31, 2018 | 41.66M |
| December 31, 2017 | 47.02M |
| September 30, 2017 | 53.52M |
| June 30, 2017 | 57.96M |
| March 31, 2017 | 58.71M |
| December 31, 2016 | 62.13M |
| September 30, 2016 | 69.04M |
| June 30, 2016 | 71.27M |
| March 31, 2016 | 76.62M |
| December 31, 2015 | 75.98M |
| September 30, 2015 | 12.29M |
| June 30, 2015 | 12.87M |
| March 31, 2015 | 15.50M |
| December 31, 2014 | 15.77M |
| September 30, 2014 | 3.264M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Orexo AB | 28.03M |
| Swedencare AB | 733.43M |
| Moberg Pharma AB | 68.50M |
| Infant Bacterial Therapeutics AB | 8.668M |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 548.27M |
| Total Liabilities (Quarterly) | 64.69M |
| Debt to Equity Ratio | 0.0232 |
| Current Ratio | 10.01 |
| Net Debt Paydown Yield | -0.00% |